Literature DB >> 27606098

The connection between pulmonary embolism and chronic thromboembolic pulmonary hypertension: research session at the American Thoracic Society 2016 Meeting.

Timothy Morris1.   

Abstract

Entities:  

Year:  2016        PMID: 27606098      PMCID: PMC4990693          DOI: 10.21037/jtd.2016.07.32

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

Review 1.  Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding.

Authors:  Irene M Lang; Raffaele Pesavento; Diana Bonderman; Jason X-J Yuan
Journal:  Eur Respir J       Date:  2012-06-14       Impact factor: 16.671

2.  Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Johannes Jakowitsch; Christopher Adlbrecht; Michael Schemper; Paul A Kyrle; Verena Schönauer; Markus Exner; Walter Klepetko; Meinhard P Kneussl; Gerald Maurer; Irene Lang
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

3.  Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events.

Authors:  Frederikus A Klok; Wendy Zondag; Klaas W van Kralingen; Arie P J van Dijk; Jouke T Tamsma; Fenna H Heyning; Hubert W Vliegen; Menno V Huisman
Journal:  Am J Respir Crit Care Med       Date:  2009-12-03       Impact factor: 21.405

4.  Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry.

Authors:  James J Marsh; Henry S Guan; Sheng Li; Peter G Chiles; Danny Tran; Timothy A Morris
Journal:  Biochemistry       Date:  2013-08-02       Impact factor: 3.162

5.  Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Johannes Jakowitsch; Bassam Redwan; Helga Bergmeister; Maria-Klara Renner; Heidi Panzenböck; Christopher Adlbrecht; Apostolos Georgopoulos; Walter Klepetko; Meinhard Kneussl; Irene M Lang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

6.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

7.  Risk factors for chronic thromboembolic pulmonary hypertension.

Authors:  D Bonderman; H Wilkens; S Wakounig; H-J Schäfers; P Jansa; J Lindner; I Simkova; A M Martischnig; J Dudczak; R Sadushi; N Skoro-Sajer; W Klepetko; I M Lang
Journal:  Eur Respir J       Date:  2008-09-17       Impact factor: 16.671

8.  Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; William R Auger; Peter F Fedullo; Virgil L Woods
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

9.  Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure.

Authors:  James J Marsh; Peter G Chiles; Ni-Cheng Liang; Timothy A Morris
Journal:  Thromb Res       Date:  2013-09-26       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.